The fling with the change stated, “We enclose the audited standalone monetary outcomes of the Firm and audited consolidated monetary outcomes of the Firm and its subsidiaries for the quarter and six-month interval ended September 30, 2025, underneath Indian Accounting Requirements, which have been accepted and brought on file at a gathering of the Board of Administrators of the Firm held at the moment.”
Additionally Learn | MF Tracker: Can this worldwide fund which gave 13% return final month maintain momentum?
“We wish to inform you that on the Board Assembly held at the moment, the Administrators have declared a second interim dividend of INR 11 per Fairness Share of INR 1 every of the Firm,” it additional added.
The corporate has reported a 1.4% development in its Q2 web revenue at Rs 12,075 crore versus Rs 11,909 crore within the 12 months in the past interval.
The revenue after tax (PAT) is attributable to the shareholders of the corporate and was under Avenue’s estimates of Rs 12,573 crore. The income from operations stood at Rs 65,799, up 2.4% over Rs 64,259 crore posted within the corresponding quarter of the final monetary 12 months.The corporate’s income was up 3.7% on a sequential foundation in comparison with Rs 63,437 crore reported in Q1FY26 whereas rising 0.8% in Fixed Foreign money.Additionally Learn | Radhika Gupta on how a 50:50 gold-silver combine labored for the trade’s first FoF
TCS’ worldwide income grew 0.6% QoQ in fixed foreign money whereas firm claimed a broad-based development throughout verticals, led by continued momentum in BFSI (+1.1% QoQ CC), TSS (+1.8% QoQ CC). The Life Sciences and Healthcare phase reported a 3.4% QoQ CC development whereas manufacturing rose 1.6% QoQ CC amidst trade particular challenges. The CMI phase rose 0.8% QoQ.
The working margin stood at 25.2% which was an growth of 70 bps QoQ. The web earnings was up 8.4% YoY whereas the online margin stood at 19.6%
as a Dependable and Trusted Information Supply
